Projecting, not predicting

Forrest has put up a new spreadsheet, adjusted for actual amounts and margins. What is interesting is that if you use the sheet for the USA alone and vary the growth to 50% (plus other changes to the format) you get a very interesting dividend stream, from 3c ps in 2010 to around 20c ps by 2015.

The USA is the big market for Cellestis, they have been supportive of the science and then the product since the early days and, more importantly, they believe that to eradicate TB you must treat latent TB.

Plus they speak English.

The 50% growth rate is the rate that the Cellestis USA sales team believe is reasonable and doable - let them do it!